Hypoxic ventilatory response in Tac1-/- neonatal mice following exposure to opioids.
Morphine is the dominating analgetic drug used in neonates, but opioid-induced respiratory depression limits its therapeutic use. In this study, we examined acute morphine effects on respiration during intermittent hypoxia in newborn Tac1 gene knockout mice (Tac1-/-) lacking substance P and neurokinin A. In vivo, plethysmography revealed a blunted hypoxic ventilatory response (HVR) in Tac1-/- mice. Morphine (10 mg/kg) depressed the HVR in wild-type animals through an effect on respiratory frequency, whereas it increased tidal volumes in Tac1-/- during hypoxia, resulting in increased minute ventilation. Apneas were reduced during the first hypoxic episode in both morphine-exposed groups, but were restored subsequently in Tac1-/- mice. Morphine did not affect ventilation or apnea prevalence during baseline conditions. In vitro, morphine (50 nM) had no impact on anoxic response of brain stem preparations of either strain. In contrast, it suppressed the inspiratory rhythm during normoxia and potentiated development of posthypoxic neuronal arrest, especially in Tac1-/-. Thus this phenotype has a higher sensitivity to the depressive effects of morphine on inspiratory rhythm generation, but morphine does not modify the reactivity to oxygen deprivation. In conclusion, although Tac1-/- mice are similar to wild-type animals during normoxia, they differed by displaying a reversed pattern with an improved HVR during intermittent hypoxia both in vivo and in vitro. These data suggest that opioids and the substance P-ergic system interact in the HVR, and that reducing the activity in the tachykinin system may alter the respiratory effects of opioid treatment in newborns.
Department of Woman and Child Health, Karolinska Institutet, Stockholm, Sweden. Jonas.Berner@ki.se
J
J
Berner
Y
Y
Shvarev
A
A
Zimmer
R
R
Wickstrom
D000701:Analgesics, Opioid / Q000633:toxicity*; D000818:Animals; D000831:Animals, Newborn; D004195:Disease Models, Animal; D005260:Female; D005838:Genotype; D000860:Hypoxia / Q000235:genetics / Q000378:metabolism* / Q000503:physiopathology; D008168:Lung / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D018345:Mice, Knockout; D009020:Morphine / Q000633:toxicity*; D009046:Motor Neurons / Q000187:drug effects / Q000378:metabolism; D010507:Periodicity; D010641:Phenotype; D010991:Plethysmography; D012123:Pulmonary Ventilation / Q000187:drug effects*; D012125:Respiratory Center / Q000187:drug effects* / Q000378:metabolism / Q000503:physiopathology; D015656:Respiratory Mechanics / Q000187:drug effects; D056152:Respiratory Rate / Q000187:drug effects; D015320:Tachykinins / Q000172:deficiency* / Q000235:genetics; D013990:Tidal Volume / Q000187:drug effects; D013997:Time Factors
D000701:Analgesics, Opioid; D015320:Tachykinins; D009020:Morphine